𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Combination therapy: a way to limit emergence of resistance?

✍ Scribed by Mehri Michea-Hamzehpour; Jean-Claude Pechere; Bruno Marchou; Raymond Auckenthaler

Book ID
115681078
Publisher
Elsevier Science
Year
1986
Tongue
English
Weight
589 KB
Volume
80
Category
Article
ISSN
1555-7162

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Saquinavir delays the emergence of zidov
Saquinavir delays the emergence of zidovudine resistance in HIV-1 seropositive patients treated with combination therapy
✍ Andreoni, M.; Sarmati, L.; Nicastri, E.; Ventura, L.; Ercoli, L.; Parisi, S. G.; πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 102 KB πŸ‘ 2 views

During a randomized double-blind study to assess the antiviral activity of saquinavir (SQV) alone or in combination with zidovudine (ZDV), the emergence of phenotypic resistance was evaluated in 44 patients treated with SQV (13 subjects), ZDV (14 subjects), and SQV plus ZDV (17 subjects). A signific

Resistance of HBV to adefovir dipivoxil:
Resistance of HBV to adefovir dipivoxil: A case for combination antiviral therapy?
✍ Costica Aloman; Jack R. Wands πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 64 KB

Background & Aims: Adefovir dipivoxil effectively inhibits both hepatitis B virus (HBV) replication and disease activity in patients with chronic hepatitis B. Resistance to treatment was not observed in 2 recent large placebo-controlled 48-week studies with this drug. The aim of this study was to ch